[Optimization of intensive therapy in neonatal hypoxic-ischemic encephalopathy]

Area of Science:

• Neonatal Medicine
• Neuroscience
• Pediatric Critical Care

Background:

• Hypoxic-ischemic encephalopathy (HIE) affects neonates, leading to significant mortality and long-term neurological deficits.
• Therapeutic hypothermia is standard care for moderate to severe HIE, but optimal management strategies require further research.
• Ongoing research addresses critical unresolved aspects of HIE intensive care.

Purpose of the Study:

• To review recent clinical studies optimizing intensive care for neonates with moderate to severe HIE.
• To evaluate the safety and feasibility of therapeutic hypothermia during transport.
• To investigate the interplay between hypothermia, hypocapnia, and inhaled CO2, and to assess hemodynamic instability and hydrocortisone therapy.

Main Methods:

• Review of recent clinical studies focusing on neonates with moderate to severe HIE.
• Analysis of controlled active hypothermia during transport.
• Examination of respiratory management, hypocapnia, inhaled CO2, hemodynamic instability, and hydrocortisone use.

Main Results:

• Controlled active hypothermia during transport is feasible and safe.
• Hypothermia is associated with hypocapnia, necessitating careful respiratory management and potentially inhaled CO2.
• Hemodynamic instability and relative adrenal insufficiency are common, with hydrocortisone showing therapeutic potential.

Conclusions:

• Optimizing intensive care for HIE involves safe transport cooling, careful respiratory management considering CO2 levels, and addressing hemodynamic instability.
• Further research into inhaled CO2 and hydrocortisone therapy may enhance neuroprotection in HIE.
• These strategies aim to improve outcomes for neonates suffering from HIE.